Researcher profile
Bobbi Fleiss
Affiliations
Organizations
Public evidence
3 connected articles
Evaluation of the efficacy of a full-spectrum medicinal cannabis plant extract with less than 0.3% Δ9-tetrahydrocannabinol in <i>in vitro</i> models of inflammation and excitotoxicity2024 · bioRxivSafety and efficacy of orally administered full-spectrum medicinal cannabis plant extract 0.08% THC (NTI-164) in children with autism spectrum disorder: An open-label study.2023 · medRxivEvaluation of the Efficacy of a Full-Spectrum Low-THC <i>Cannabis</i> Plant Extract Using In Vitro Models of Inflammation and Excitotoxicity.2024 · Europe PMC
Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.